Merck finalizes $41 billion merger with Schering-Plough
Merck & Co. completed its $41 billion takeover of Schering-Plough, allowing the companies to begin operating as one entity today. The consolidation is expected to dramatically boost Merck's global expansion while bringing in a diverse pipeline of treatments, including those for cancer, women's health and infectious diseases.
Google | 11/03
This story published in BIO SmartBrief on 11/04/2009
More from SmartBrief:
Researchers end trial comparing cholesterol drugs Niaspan, Zetia
Friday, July 10, 2009
Most execs to come from Merck after merger with Schering
Tuesday, September 1, 2009
FDA decides against Lipitor-Zetia combo
Tuesday, November 3, 2009
Get stories like these delivered daily for FREE:
|
BIO SmartBrief
Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more |
|